Paul W. Manley

Person

Arleshiem, CH

People

Patents Grantslast 30 patents

Information Patent Grant
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and...
- Patent number 9,896,444
- Issue date Feb 20, 2018
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibiting the activity of ABL1, ABL...
- Patent number 9,458,112
- Issue date Oct 4, 2016
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and...
- Patent number 9,340,537
- Issue date May 17, 2016
- Novatis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibiting the activity of ABL1, ABL...
- Patent number 9,315,489
- Issue date Apr 19, 2016
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds and compositions for inhibiting the activity of ABL1, ABL...
- Patent number 9,278,981
- Issue date Mar 8, 2016
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Patent number 9,163,005
- Issue date Oct 20, 2015
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...
- Patent number 8,829,015
- Issue date Sep 9, 2014
- Novartis AG
- Paul W. Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions for inhibiting the activity of ABL1, ABL...
- Patent number 8,829,195
- Issue date Sep 9, 2014
- Novartis AG
- Stephanie Kay Dodd
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidylaminobenzamide derivatives for systemic mastocytosis
- Patent number 8,673,930
- Issue date Mar 18, 2014
- Novartis AG
- Leila Alland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of pyrimidylaminobenzamide compounds and imatinib for t...
- Patent number 8,653,093
- Issue date Feb 18, 2014
- Novartis AG
- Leila Alland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pyrimidylaminobenzamide derivatives for treatment of neurofibromatosis
- Patent number 8,604,045
- Issue date Dec 10, 2013
- Novartis AG
- Paul W. Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Patent number 8,580,806
- Issue date Nov 12, 2013
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Compounds and compositions as protein kinase inhibitors
- Patent number 8,552,002
- Issue date Oct 8, 2013
- Novartis AG
- Qiang Ding
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyr...
- Patent number 8,513,256
- Issue date Aug 20, 2013
- Novartis AG
- Hans Michael Bürger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine k...
- Patent number 8,445,479
- Issue date May 21, 2013
- Novartis AG
- James Douglas Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...
- Patent number 8,415,363
- Issue date Apr 9, 2013
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Patent number 8,389,537
- Issue date Mar 5, 2013
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...
- Patent number 8,343,984
- Issue date Jan 1, 2013
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of c-Src inhibitors alone or in combination with STI571 for the...
- Patent number 8,268,837
- Issue date Sep 18, 2012
- Novartis AG
- Nicholas J Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine k...
- Patent number 8,222,244
- Issue date Jul 17, 2012
- Novartis AG
- James D Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Organic compounds
- Patent number 8,217,045
- Issue date Jul 10, 2012
- Novartis AG
- Paul W. Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Patent number 8,163,904
- Issue date Apr 24, 2012
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterobicyclic carboxamides as inhibitors for kinases
- Patent number 8,133,886
- Issue date Mar 13, 2012
- Novartis AG
- Guido Bold
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Use of c-Src inhibitors alone or in combination with STI571 for the...
- Patent number 8,119,649
- Issue date Feb 21, 2012
- Novartis AG
- Nicholas J Donato
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H...
- Patent number 8,093,259
- Issue date Jan 10, 2012
- Novartis AG
- Paul W Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Phthalazine derivatives with angiogenesis inhibiting activity
- Patent number 8,034,814
- Issue date Oct 11, 2011
- Novartis AG
- Guido Bold
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Bicyclic amides as kinase inhibitors
- Patent number 8,026,247
- Issue date Sep 27, 2011
- Novartis AG
- Guido Bold
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine k...
- Patent number 7,973,031
- Issue date Jul 5, 2011
- Novartis AG
- James Douglas Griffin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of tyrosine kinases
- Patent number 7,956,053
- Issue date Jun 7, 2011
- Novartis AG
- Werner Breitenstein
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cyclic diaryl ureas suitable as tyrosine kinase inhibitors
- Patent number 7,855,215
- Issue date Dec 21, 2010
- Novartis AG
- Guido Bold
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...
- Publication number 20180134695
- Publication date May 17, 2018
- Novartis AG
- Pascal FURET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND...
- Publication number 20160200705
- Publication date Jul 14, 2016
- Novartis AG
- Pascal FURET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...
- Publication number 20160185733
- Publication date Jun 30, 2016
- Novartis AG
- Pascal FURET
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Methods and Compositions for Treating Luekemia
- Publication number 20150209365
- Publication date Jul 30, 2015
- Novartis AG
- Mhairi Copland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...
- Publication number 20150183801
- Publication date Jul 2, 2015
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...
- Publication number 20150141427
- Publication date May 21, 2015
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND...
- Publication number 20150126485
- Publication date May 7, 2015
- Novartis AG
- Pascal Furet
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...
- Publication number 20140343087
- Publication date Nov 20, 2014
- Novartis AG
- Paul W. Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...
- Publication number 20140343086
- Publication date Nov 20, 2014
- Novartis AG
- Stephanie Kay DODD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-OXIDES OF N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
- Publication number 20140323494
- Publication date Oct 30, 2014
- Novartis AG
- Klaus O. Börnsen
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis
- Publication number 20140073660
- Publication date Mar 13, 2014
- Novartis AG
- Paul W. Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyr...
- Publication number 20140051853
- Publication date Feb 20, 2014
- Novartis AG
- Hans Michael Bürger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Publication number 20140038994
- Publication date Feb 6, 2014
- Novartis AG
- Paul W. Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...
- Publication number 20130310395
- Publication date Nov 21, 2013
- Novartis AG
- Stephanie Kay DODD
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fib...
- Publication number 20130267549
- Publication date Oct 10, 2013
- Novartis AG
- Elisabeth BUCHDUNGER
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDY...
- Publication number 20130197017
- Publication date Aug 1, 2013
- Paul W Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...
- Publication number 20130165465
- Publication date Jun 27, 2013
- Novartis AG
- Paul W Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Publication number 20130137712
- Publication date May 30, 2013
- Novartis AG
- Paul W. Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis
- Publication number 20130123290
- Publication date May 16, 2013
- Novartis AG
- Paul W. Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF c-Src INHIBITORS IN COMBINATION WITH A PYRIMIDYLAMINOBENZAMI...
- Publication number 20130040972
- Publication date Feb 14, 2013
- Paul W. Manley
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...
- Publication number 20130023548
- Publication date Jan 24, 2013
- Paul W. MANLEY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
- Publication number 20130012704
- Publication date Jan 10, 2013
- Qiang DING
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS
- Publication number 20130012476
- Publication date Jan 10, 2013
- Qiang DING
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR TREATING LUEKEMIA
- Publication number 20120329798
- Publication date Dec 27, 2012
- Mhairi Copland
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...
- Publication number 20120270891
- Publication date Oct 25, 2012
- Paul W. Manley
- C07 - ORGANIC CHEMISTRY
Information Patent Application
STAUROSPORINE DERIVATIVES AS INHIBITORS OF FLT3 RECEPTOR TYROSINE K...
- Publication number 20120252785
- Publication date Oct 4, 2012
- Novartis AG
- James Douglas GRIFFIN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER
- Publication number 20120252811
- Publication date Oct 4, 2012
- Gregory Peter Burke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyr...
- Publication number 20120142697
- Publication date Jun 7, 2012
- Hans Michael Burger
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES
- Publication number 20120122857
- Publication date May 17, 2012
- Novartis AG
- Guido BOLD
- C07 - ORGANIC CHEMISTRY
Information Patent Application
USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF DIS...
- Publication number 20120015968
- Publication date Jan 19, 2012
- Novartis AG
- Doriano Fabbro
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Paul W. Manley

Person

Patents Grantslast 30 patents

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and...

Compounds and compositions for inhibiting the activity of ABL1, ABL...

Benzamide derivatives for inhibiting the activity of ABL1, ABL2 and...

Compounds and compositions for inhibiting the activity of ABL1, ABL...

Compounds and compositions for inhibiting the activity of ABL1, ABL...

Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...

Compounds and compositions for inhibiting the activity of ABL1, ABL...

Pyrimidylaminobenzamide derivatives for systemic mastocytosis

Combination of pyrimidylaminobenzamide compounds and imatinib for t...

Pyrimidylaminobenzamide derivatives for treatment of neurofibromatosis

Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

Compounds and compositions as protein kinase inhibitors

Salt forms of 4-(4-methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyr...

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine k...

Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...

Salts of 4-methyl N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

Crystalline forms of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...

Use of c-Src inhibitors alone or in combination with STI571 for the...

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine k...

Organic compounds

Salts of 4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

Heterobicyclic carboxamides as inhibitors for kinases

Use of c-Src inhibitors alone or in combination with STI571 for the...

4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H...

Phthalazine derivatives with angiogenesis inhibiting activity

Bicyclic amides as kinase inhibitors

Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine k...

Inhibitors of tyrosine kinases

Cyclic diaryl ureas suitable as tyrosine kinase inhibitors

Patents Applicationslast 30 patents

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...

BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...

Methods and Compositions for Treating Luekemia

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...

BENZAMIDE DERIVATIVES FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND...

Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...

N-OXIDES OF N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES

Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis

Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyr...

Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL...

Use of Pyrimidylaminobenzamide Derivatives for the Treatment of Fib...

COMBINATIONS COMPRISING A PROTEIN KINASE INHIBITOR BEING A PYRIMIDY...

Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...

Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

Pyrimidylaminobenzamide Derivatives for Treatment of Neurofibromatosis

USE OF c-Src INHIBITORS IN COMBINATION WITH A PYRIMIDYLAMINOBENZAMI...

Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifl...

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

COMPOUNDS AND COMPOSITIONS AS PROTEIN KINASE INHIBITORS

METHODS AND COMPOSITIONS FOR TREATING LUEKEMIA

Salts of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-p...

STAUROSPORINE DERIVATIVES AS INHIBITORS OF FLT3 RECEPTOR TYROSINE K...

COMBINATIONS OF THERAPEUTIC AGENTS FOR TREATING CANCER

Salt forms of 4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyr...

HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES

USE OF PYRIMIDYLAMINOBENZAMIDE DERIVATIVES FOR THE TREATMENT OF DIS...